Skip to main content
PMC home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1980;14:55–59.

Clinical applications of fibrinolytic inhibition in gynaecology

J Bonnar 1,2,3, J Guillebaud 1,2,3, JM Kasonde 1,2,3, BL Sheppard 1,2,3
PMCID: PMC1347107  PMID: 7000848

Full text

PDF
57

Images in this article

57Image
on p.57
57Image
on p.57

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRECHTSEN O. K. The fibrinolytic activity of human tissues. Br J Haematol. 1957 Jul;3(3):284–291. doi: 10.1111/j.1365-2141.1957.tb05798.x. [DOI] [PubMed] [Google Scholar]
  2. ALBRECHTSEN O. K. The fibrinolytic activity of the human endometrium. Acta Endocrinol (Copenh) 1956 Oct;23(2):207–218. doi: 10.1530/acta.0.0230207. [DOI] [PubMed] [Google Scholar]
  3. ASTRUP T. The haemostatic balance. Thromb Diath Haemorrh. 1958 Sep 1;2(3-4):347–357. [PubMed] [Google Scholar]
  4. Astedt B., Nilsson I. M. Recurrent abruptio placentae treated with the fibrinolytic inhibitor tranexamic acid. Br Med J. 1978 Mar 25;1(6115):756–757. doi: 10.1136/bmj.1.6115.756-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Basu H. K. Fibrin degradation products in sera of women with normal menstruation and menorrhagia. Br Med J. 1970 Jan 10;1(5688):74–75. doi: 10.1136/bmj.1.5688.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bonnar J., Kasonde K., Haddon M., Hassanein M. K., Allington M. J. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices. Br J Obstet Gynaecol. 1976 Feb;83(2):160–164. doi: 10.1111/j.1471-0528.1976.tb00800.x. [DOI] [PubMed] [Google Scholar]
  7. Callender S. T., Warner G. T., Cope E. Treatment of menorrhagia with tranexamic acid. A double-blind trial. Br Med J. 1970 Oct 24;4(5729):214–216. doi: 10.1136/bmj.4.5729.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cole S. K., Clarkson A. R. Menstrual blood loss and fibrin degradation products. Br Med J. 1972 Jan 8;1(5792):78–79. doi: 10.1136/bmj.1.5792.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Glas-Greenwalt P., Beller F. K., Astrup T. Comparative assays of tissue plasminogen activator in myometrium, cervix, and fibromyomas of the human uterus. Am J Obstet Gynecol. 1971 Jul 1;110(5):721–725. doi: 10.1016/0002-9378(71)90260-2. [DOI] [PubMed] [Google Scholar]
  10. Guillebaud J., Bonnar J. Longer though lighter menstrual and intermenstural bleeding with copper as compared to inert intrauterine devices. Br J Obstet Gynaecol. 1978 Sep;85(9):707–712. doi: 10.1111/j.1471-0528.1978.tb14951.x. [DOI] [PubMed] [Google Scholar]
  11. Kasonde J. M., Bonnar J. Aminocaproic acid and menstrual loss in women using intrauterine devices. Br Med J. 1975 Oct 4;4(5987):17–19. doi: 10.1136/bmj.4.5987.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kasonde J. M., Bonnar J. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices. Br Med J. 1975 Oct 4;4(5987):21–22. doi: 10.1136/bmj.4.5987.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. NILSSON I. M., BJOERKMAN S. E. EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID (EPSILON-ACA) IN THE TREATMENT OF PROFUSE MENSTRUATION. Acta Med Scand. 1965 Apr;177:445–457. [PubMed] [Google Scholar]
  14. NILSSON I. M., BJORKMAN S. E., ANDERSSON L. Clinical experiences with 6-aminocaproic acid (6-ACA) as an antifibrinolytic agent. Acta Med Scand. 1961 Oct;170:487–509. doi: 10.1111/j.0954-6820.1961.tb00264.x. [DOI] [PubMed] [Google Scholar]
  15. Nilsson L., Rybo G. Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation. Acta Obstet Gynecol Scand. 1965;44(3):467–473. doi: 10.3109/00016346509155880. [DOI] [PubMed] [Google Scholar]
  16. Nilsson L., Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol. 1971 Jul 1;110(5):713–720. doi: 10.1016/0002-9378(71)90259-6. [DOI] [PubMed] [Google Scholar]
  17. Rybo G. Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss. Acta Obstet Gynecol Scand. 1966;45(4):429–450. doi: 10.3109/00016346609158462. [DOI] [PubMed] [Google Scholar]
  18. Sheppard B. L., Bonnar J. Fibrinolysis in decidual spiral arteries in late pregnancy. Thromb Haemost. 1978 Jun 30;39(3):751–758. [PubMed] [Google Scholar]
  19. Vermylen J., Verhaegen-Declercq M. L., Verstraete M., Fierens F. A double blind study of the effect of tranexamic acid in essential menorrhagia. Thromb Diath Haemorrh. 1968 Dec 31;20(3):583–587. [PubMed] [Google Scholar]
  20. Weiss G., Beller F. K. Tissue activator of the fibrinolytic enzyme in the female reproductive system. Obstet Gynecol. 1969 Dec;34(6):809–819. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES